Insulin-like growth factors (IGF) and IGF binding proteins in children with chronic renal failure

Progress in Growth Factor Research

Volumn 6, Issue 2-4, 1995, Pages 481-491

  Tönshoff, Burkhard ^c   Blum, Werner F ^b   Mehls, Otto ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

^c NONE

Author keywords

chronic renal failure; growth hormone; growth retardation; insulin like growth factor binding proteins; Insulin like growth factors

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

CHILD; CHRONIC KIDNEY FAILURE; HUMAN; METABOLISM; REVIEW;

CHILD; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KIDNEY FAILURE, CHRONIC; SOMATOMEDINS;

EID: 0029432793     PISSN: 09552235     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-2235(96)00003-8     Document Type: Article

References (49)

1. Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment
2. Cartilage as a Target Tissue for Growth Hormone and Insulin-Like Growth Factor I
3. Insulin and Insulin-like Growth Factor Receptors and Responses
4. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene
5. Isolation and molecular characterization of three novel insulin-like growth factor binding proteins (IGFBP-4, 5 and 6)
6. Regulation and function of insulin-like growth factor-binding protein-1
7. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured chrriocarcinoma cells
8. The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I mediated growth of chick embryo pelvic cartilages in vitro
9. Serum concentrations of insulin-like growth factor (IGF)-I, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure
10. Characterization of insulin-like growth factor binding proteins in human serum from patients with chronic renal failure
11. High molecular weight insulin-like growth factor binding protein complex
12. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growh hormone secretion
13. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts
14. Structural and biological characterization of bovine insulin-like growth factor binding protein-3
15. Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I
16. Insulin-like growth factor-binding protein (IGF-BP) inhibition of granulosa cell function: effect on cyclic adenosine 3′, 5′-monophosphate, deoxyribonucleic acid synthesis, and comparison with the effect of an IGF-I antibody
17. Insulin-like growth factor binding proteins. A review of methodological aspects of their purification, analysis and regulation
18. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor 1 (IGF 1) and IGF 2 in acid-chromatographed uremic serum
19. Radioimmunoassays for IGFs
20. A specific radiommunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I
21. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood.
22. Serum insulin-like growth factors and their binding proteins in children with end-stage renal disease.
23. IGF binding proteins in growth-retarded children with chronic renal failure
24. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia
25. Effects of Two Years of Growth Hormone Treatment in Short Children with Renal Disease
26. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates
27. Deconvolution Analysis of Spontaneous Nocturnal Growth Hormone Secretion in Prepubertal Children with Preterminal Chronic Renal Failure and with End-Stage Renal Disease
28. Insulin-Like Growth Factors (IGFs) and IGF Binding Proteins in Chronic Renal Failure: Evidence for Reduced Secretion of IGFs
29. Decreased hepatic insulin-like growth factor (IGF)-I and increased IGF binding protein (IGFBP)-1 and -2 gene expression in experimental uremia
30. Plasma growth hormone binding protein is low in uraemic children
31. Reduced concentration of serum growth hormone-binding protein (GHBP) in children with chronic renal insufficiency (CRI)
32. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia
33. Excess of IGF-binding proteins in chronic renal failure: evidence for relative GH resistance and inhibition of somatomedin activity
34. Characterization of insulin-like growth factor binding protein-3 in chronic renal failure serum
35. IGF binding protein-3 and the acid-labile subunit. Formation of the ternary complex in vitro and in vivo
36. Renal filtration, transport, and metabolism of low-molecular weight proteins: a review
37. Nutritional regulation of the insulin-like growth factors
38. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone
39. Tissue expression and chromosomal localization of the human insulin-like growth factor protein 3
40. Proteases acting on IGFBPs: their occurrence and physiological significance
41. Alterations in insulin-like growth factor binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure
42. Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph
43. Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein
44. Somatomedin inhibitor in uremia
45. Recombinant human insulin-like growth factor (IGF) binding protein-1 inhibits somatic grwoth stimulated by IGF-1 and growth hormone in hypophysectomized rats
46. Growth retardation and altered glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice
47. Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease
48. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure
49. Growth hormone (GH) stimulates growth and alters the serum insulin-like growth factor (IGF) axis of children with chronic renal failure (CRF)